Pub Date : 2026-03-01Epub Date: 2025-12-09DOI: 10.1016/j.jchf.2025.102826
Jennifer E. Ho MD , Sanjeeb S. Bhattacharya MD
{"title":"BMI in HFpEF","authors":"Jennifer E. Ho MD , Sanjeeb S. Bhattacharya MD","doi":"10.1016/j.jchf.2025.102826","DOIUrl":"10.1016/j.jchf.2025.102826","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"14 3","pages":"Article 102826"},"PeriodicalIF":11.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145704308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-10-29DOI: 10.1016/j.jchf.2025.102727
Ankeet S. Bhatt MD, MBA, ScM , Diana De Oliveira-Gomes MD , Mona Fiuzat PharmD , Muthiah Vaduganathan MD, MPH , Carine E. Hamo MD, MHS , Norman Stockbridge MD, PhD , Javed Butler MD, MPH, MBA , Mitchell Psotka MD, PhD , William T. Abraham MD , Darren K. McGuire MD, MHSc , Trejeeve Martyn MD, MSc , Barry H. Greenberg MD , Christopher M. O’Connor MD , Scott D. Solomon MD
{"title":"Assessing Medical Therapy Optimization in Cardiovascular-Kidney-Metabolic Clinical Trials","authors":"Ankeet S. Bhatt MD, MBA, ScM , Diana De Oliveira-Gomes MD , Mona Fiuzat PharmD , Muthiah Vaduganathan MD, MPH , Carine E. Hamo MD, MHS , Norman Stockbridge MD, PhD , Javed Butler MD, MPH, MBA , Mitchell Psotka MD, PhD , William T. Abraham MD , Darren K. McGuire MD, MHSc , Trejeeve Martyn MD, MSc , Barry H. Greenberg MD , Christopher M. O’Connor MD , Scott D. Solomon MD","doi":"10.1016/j.jchf.2025.102727","DOIUrl":"10.1016/j.jchf.2025.102727","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"14 3","pages":"Article 102727"},"PeriodicalIF":11.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145382709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-12-13DOI: 10.1016/j.jchf.2025.102841
Rayan Yousefzai MD , Arvind Bhimaraj MD , Michael S. Kiernan MD, MPH , Jacob Abraham MD , Irakli Gorgoshvili MD , Ryan J. Tedford MD , Shashank Desai MD , Esther E. Vorovich MD , Keith H. Benzuly MD , David Miranda MD , Manreet K. Kanwar MD , Andrew J. Sauer MD , Debbie A. Rinde-Hoffman MD , Ioana Dumitru MD , Jaime Hernandez-Montfort MD , Nima Aghili MD , Farooq H. Sheikh MD , Anupam Basuray MD , Jason Bodnar PhD , Jerry Curran PhD , Navin K. Kapur MD
Background
The preCARDIA device is a novel intervention designed to mechanically reduce cardiac filling pressures in patients with acute decompensated heart failure (ADHF) by regulating flow through the superior vena cava.
Objectives
The VENUS-HF (SVC Occlusion in Subjects With Acute Decompensated Heart Failure; NCT03836079) Early Feasibility Study tested the safety and feasibility of the next-generation preCARDIA system, which includes updates to the sheath, catheter, and console.
Methods
In a multicenter, prospective, single-arm safety and feasibility study, 60 subjects with ADHF received preCARDIA support for up to 24 hours. Primary and secondary endpoints testing the safety and technical feasibility of the device were analyzed.
Results
Freedom from device- or procedure-related major adverse events was observed in 98.3% (n = 59/60), and successful device deployment and removal in all subjects (N = 60). No statistically significant difference in major adverse events was observed between recipients of the original (0%, n = 0/30) and newest (3.3%, n = 1/30) generation preCARDIA devices. In subjects with 24 ± 3 hours of preCARDIA duration (n = 52), paired right atrial and pulmonary capillary wedge pressures decreased by 23% (18 ± 6 vs 11 ± 6 mm Hg, P < 0.0001) and 18% (30 ± 8 vs 24 ± 9 mm Hg, P < 0.0001), respectively, from baseline to end of device use. Compared with 24 hours before device initiation, net urine output increased during the 24-hour period during device use (−1.5 ± 0.9 vs −3.4 ± 2.4 L, P < 0.001).
Conclusions
Use of the preCARDIA system in patients with ADHF was feasible and well tolerated, with early exploratory signals of significantly reduced cardiac filling pressures and increased urine output. These findings provide a foundation for larger, prospective studies, such as the upcoming COR-ADHF (Cardiovascular UnlOading with preCARDIA in Acute Decompensated Heart Failure) trial, to determine clinical efficacy. (SVC Occlusion in Subjects With Acute Decompensated Heart Failure [VENUS-HF]; NCT03836079)
背景:preCARDIA装置是一种新型的干预措施,旨在通过调节上腔静脉的血流来机械地降低急性失代偿性心力衰竭(ADHF)患者的心脏充盈压力。目的:急性失代偿性心力衰竭患者的SVC闭塞(VENUS-HF)早期可行性研究测试了下一代preCARDIA系统的安全性和可行性,该系统包括对护套、导管和控制台的更新。方法在一项多中心、前瞻性、单臂安全性和可行性研究中,60例ADHF患者接受了长达24小时的preCARDIA支持。对试验装置的主要和次要终点进行了安全性和技术可行性分析。结果98.3%的受试者(n = 59/60)没有发生与器械或手术相关的主要不良事件,所有受试者(n = 60)均成功放置和取出器械。原始(0%,n = 0/30)和最新(3.3%,n = 1/30)一代preCARDIA器械受者的主要不良事件无统计学差异。在持续24±3小时的受试者中(n = 52),从基线到器械使用结束,配对右心房和肺毛细血管楔压分别下降了23%(18±6 vs 11±6 mm Hg, P < 0.0001)和18%(30±8 vs 24±9 mm Hg, P < 0.0001)。与装置启动前24小时相比,在使用装置的24小时内,净尿量增加(- 1.5±0.9 L vs - 3.4±2.4 L, P < 0.001)。结论在ADHF患者中应用preCARDIA系统是可行且耐受性良好的,早期探查信号可显著降低心脏充盈压力和增加尿量。这些发现为更大规模的前瞻性研究提供了基础,例如即将进行的COR-ADHF(急性失代偿性心力衰竭中心血管卸载与preCARDIA)试验,以确定临床疗效。急性失代偿性心力衰竭患者的SVC闭塞[VENUS-HF]; NCT03836079)
{"title":"Mechanically Reducing Cardiac Preload With the preCARDIA System in Acutely Decompensated Heart Failure","authors":"Rayan Yousefzai MD , Arvind Bhimaraj MD , Michael S. Kiernan MD, MPH , Jacob Abraham MD , Irakli Gorgoshvili MD , Ryan J. Tedford MD , Shashank Desai MD , Esther E. Vorovich MD , Keith H. Benzuly MD , David Miranda MD , Manreet K. Kanwar MD , Andrew J. Sauer MD , Debbie A. Rinde-Hoffman MD , Ioana Dumitru MD , Jaime Hernandez-Montfort MD , Nima Aghili MD , Farooq H. Sheikh MD , Anupam Basuray MD , Jason Bodnar PhD , Jerry Curran PhD , Navin K. Kapur MD","doi":"10.1016/j.jchf.2025.102841","DOIUrl":"10.1016/j.jchf.2025.102841","url":null,"abstract":"<div><h3>Background</h3><div>The preCARDIA device is a novel intervention designed to mechanically reduce cardiac filling pressures in patients with acute decompensated heart failure (ADHF) by regulating flow through the superior vena cava.</div></div><div><h3>Objectives</h3><div>The VENUS-HF (SVC Occlusion in Subjects With Acute Decompensated Heart Failure; <span><span>NCT03836079</span><svg><path></path></svg></span>) Early Feasibility Study tested the safety and feasibility of the next-generation preCARDIA system, which includes updates to the sheath, catheter, and console.</div></div><div><h3>Methods</h3><div>In a multicenter, prospective, single-arm safety and feasibility study, 60 subjects with ADHF received preCARDIA support for up to 24 hours. Primary and secondary endpoints testing the safety and technical feasibility of the device were analyzed.</div></div><div><h3>Results</h3><div>Freedom from device- or procedure-related major adverse events was observed in 98.3% (n = 59/60), and successful device deployment and removal in all subjects (N = 60). No statistically significant difference in major adverse events was observed between recipients of the original (0%, n = 0/30) and newest (3.3%, n = 1/30) generation preCARDIA devices. In subjects with 24 ± 3 hours of preCARDIA duration (n = 52), paired right atrial and pulmonary capillary wedge pressures decreased by 23% (18 ± 6 vs 11 ± 6 mm Hg, <em>P</em> < 0.0001) and 18% (30 ± 8 vs 24 ± 9 mm Hg, <em>P</em> < 0.0001), respectively, from baseline to end of device use. Compared with 24 hours before device initiation, net urine output increased during the 24-hour period during device use (−1.5 ± 0.9 vs −3.4 ± 2.4 L, <em>P</em> < 0.001).</div></div><div><h3>Conclusions</h3><div>Use of the preCARDIA system in patients with ADHF was feasible and well tolerated, with early exploratory signals of significantly reduced cardiac filling pressures and increased urine output. These findings provide a foundation for larger, prospective studies, such as the upcoming COR-ADHF (Cardiovascular UnlOading with preCARDIA in Acute Decompensated Heart Failure) trial, to determine clinical efficacy. (SVC Occlusion in Subjects With Acute Decompensated Heart Failure [VENUS-HF]; <span><span>NCT03836079</span><svg><path></path></svg></span>)</div></div>","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"14 3","pages":"Article 102841"},"PeriodicalIF":11.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145731054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-10-28DOI: 10.1016/j.jchf.2025.102725
Jonathan Grinstein MD , Van-Khue Ton MD, PhD , Sara Kalantari MD , Jennifer A. Cowger MD, MS , Manreet Kanwar MD
{"title":"Current Use of Inotropic Support in Cardiogenic Shock","authors":"Jonathan Grinstein MD , Van-Khue Ton MD, PhD , Sara Kalantari MD , Jennifer A. Cowger MD, MS , Manreet Kanwar MD","doi":"10.1016/j.jchf.2025.102725","DOIUrl":"10.1016/j.jchf.2025.102725","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"14 3","pages":"Article 102725"},"PeriodicalIF":11.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145374184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2025-11-20DOI: 10.1016/j.jchf.2025.102771
Karim Kohansal Vajargah MD , Marie-Joe Dib PhD , Hamed Tavolinejad MD , Payman Zamani MD, MTR , A. Mark Richards MD, PhD , Douglas L. Mann MD , Ernst Rietzschel MD, PhD , Vanessa van Empel MD, PhD , Stephen Burgess PhD , Thomas P. Cappola MD, SM , Julio A. Chirinos MD, PhD
{"title":"Proteome-Wide Genetic Investigation of Kidney Function in Heart Failure With Preserved Ejection Fraction","authors":"Karim Kohansal Vajargah MD , Marie-Joe Dib PhD , Hamed Tavolinejad MD , Payman Zamani MD, MTR , A. Mark Richards MD, PhD , Douglas L. Mann MD , Ernst Rietzschel MD, PhD , Vanessa van Empel MD, PhD , Stephen Burgess PhD , Thomas P. Cappola MD, SM , Julio A. Chirinos MD, PhD","doi":"10.1016/j.jchf.2025.102771","DOIUrl":"10.1016/j.jchf.2025.102771","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"14 3","pages":"Article 102771"},"PeriodicalIF":11.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145559691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-03-01Epub Date: 2026-01-05DOI: 10.1016/j.jchf.2025.102853
Palak Shah MD, MS, Shashank S. Sinha MD, MSc
{"title":"Guideline-Directed Medical Therapy for Patients With a Left Ventricular Assist Device","authors":"Palak Shah MD, MS, Shashank S. Sinha MD, MSc","doi":"10.1016/j.jchf.2025.102853","DOIUrl":"10.1016/j.jchf.2025.102853","url":null,"abstract":"","PeriodicalId":14687,"journal":{"name":"JACC. Heart failure","volume":"14 3","pages":"Article 102853"},"PeriodicalIF":11.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145902524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}